Participants 106 135 3
Children's Cancer Group study
Participants 403 489 5
462 patients with disseminated disease, 49 (10.6%) had CNS disease at diagnosis (CNS+)
Participants 658 746 3
CNS+ patients, 28 had M2 (5% to 25% blasts) or M3 (> 25% blasts) bone marrow involvement
